Investigating bioelectric therapy for dry AMD

The investigational i-LUMEN AMD System® is being evaluated in clinical studies for patients with intermediate to advanced dry AMD.

Evidence

Clinical research

i-Lumen Scientific’s clinical program is evaluating the investigational i-LUMEN™ AMD System in patients with intermediate to advanced nonexudative (dry) age-related macular degeneration (AMD).

Completed

i-SIGHT clinical study

The i-SIGHT study was a randomized, sham-controlled clinical trial evaluating the investigational i-LUMEN™ AMD System in patients with intermediate to advanced dry AMD.

The study evaluated the safety and performance of non-invasive bioelectric stimulation delivered through the eyelid.

Currently enrolling

i-SIGHT2 Clinical Study

The i-SIGHT2 study is a multicenter clinical trial evaluating the safety and effectiveness of the investigational i-LUMEN™ AMD System in patients with intermediate to advanced dry AMD.

evidence

Clinical research

i-Lumen Scientific’s clinical program is evaluating the i-Lumen AMD System, an investigational medical device*, in patients with intermediate to advanced nonexudative (dry) age-related macular degeneration (AMD).

Completed

i-SIGHT Study

For more information, please visit the trial site using the link below.

In progress

i-SIGHT2 Study

The i-SIGHT2 study is a multicenter clinical trial evaluating the safety and effectiveness of the i-LUMEN AMD System® in patients with intermediate to advanced dry AMD.

Scientific publications and presentations

The i-LUMEN clinical research program has been presented at leading ophthalmology and vision science meetings.